Petroleo Brasileiro SA Petrobras
PBR
Vale SA
VALE
Ecopetrol
EC
4
Taylor Morrison Home
TMHC
5
KB Home
KBH
US Stock MarketDetailed Quotes
ATOS Atossa Therapeutics
- 0.6962
- -0.0024-0.34%
Close Mar 28 16:00 ET
- 0.7100
- +0.0138+1.98%
Post 20:01 ET
89.93MMarket Cap-3.48P/E (TTM)
0.7023High0.6800Low435.14KVolume0.6969Open0.6986Pre Close300.72KTurnover0.34%Turnover RatioLossP/E (Static)129.17MShares1.970052wk High1.26P/B89.88MFloat Cap0.660052wk Low--Dividend TTM129.10MShs Float2231.9981Historical High--Div YieldTTM3.19%Amplitude0.5000Historical Low0.6910Avg Price1Lot Size
Atossa Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -11.97%27.62M | -20.71%7.15M | -14.50%6.39M | -8.83%7.11M | -1.66%6.98M | 13.31%31.38M | 10.83%9.02M | -8.98%7.47M | 18.17%7.79M | 49.53%7.1M |
| Selling and administrative expenses | -3.84%13.5M | 11.38%3.75M | -0.93%2.97M | -13.11%3.55M | -9.97%3.23M | 11.38%14.04M | 6.76%3.37M | -1.44%3M | 29.29%4.09M | 10.53%3.59M |
| -General and administrative expense | -3.84%13.5M | 11.38%3.75M | -0.93%2.97M | -13.11%3.55M | -9.97%3.23M | 11.38%14.04M | 6.76%3.37M | -1.44%3M | 29.29%4.09M | 10.53%3.59M |
| Research and development costs | -18.56%14.12M | -39.81%3.4M | -23.62%3.41M | -4.10%3.55M | 6.84%3.75M | 14.92%17.33M | 13.40%5.65M | -13.43%4.47M | 7.92%3.71M | 134.02%3.51M |
| Operating profit | 11.97%-27.62M | 20.71%-7.15M | 14.50%-6.39M | 8.83%-7.11M | 1.66%-6.98M | -13.31%-31.38M | -10.83%-9.02M | 8.98%-7.47M | -18.17%-7.79M | -49.53%-7.1M |
| Net non-operating interest income expense | -6.75%4.05M | -32.28%837K | -21.43%1M | 9.16%1.07M | 33.88%1.14M | 395.21%4.34M | 84.48%1.24M | 556.70%1.27M | 8,836.36%983K | 84,900.00%850K |
| Non-operating interest income | -6.75%4.05M | -32.28%837K | -21.43%1M | 9.16%1.07M | 33.88%1.14M | 395.21%4.34M | 84.48%1.24M | 556.70%1.27M | 8,836.36%983K | 84,900.00%850K |
| Other net income (expense) | 36.83%-1.93M | -213.79%-33K | -5,174.29%-1.85M | 99.44%-17K | -9.09%-36K | -1,995.89%-3.06M | 226.09%29K | -35K | -3,331.82%-3.02M | 17.50%-33K |
| Special income (charges) | 42.81%-1.71M | --0 | ---1.71M | --0 | ---- | ---2.99M | --0 | --0 | ---2.99M | ---- |
| -Write off | -42.81%1.71M | --0 | --1.71M | --0 | ---- | --2.99M | --0 | --0 | --2.99M | ---- |
| Other non- operating income (expenses) | -218.57%-223K | -213.79%-33K | -288.57%-136K | 43.33%-17K | -9.09%-36K | 52.05%-70K | 226.09%29K | ---35K | 65.91%-30K | 17.50%-33K |
| Income before tax | 15.25%-25.5M | 18.15%-6.35M | -16.07%-7.23M | 38.46%-6.05M | 6.42%-5.88M | -11.62%-30.09M | -3.51%-7.75M | 22.24%-6.23M | -47.33%-9.83M | -31.24%-6.28M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | 15.25%-25.5M | 18.15%-6.35M | -16.07%-7.23M | 38.46%-6.05M | 6.42%-5.88M | -11.62%-30.09M | -3.51%-7.75M | 22.24%-6.23M | -47.33%-9.83M | -31.24%-6.28M |
| Net income continuous Operations | 15.25%-25.5M | 18.15%-6.35M | -16.07%-7.23M | 38.46%-6.05M | 6.42%-5.88M | -11.62%-30.09M | -3.51%-7.75M | 22.24%-6.23M | -47.33%-9.83M | -31.24%-6.28M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 15.25%-25.5M | 18.15%-6.35M | -16.07%-7.23M | 38.46%-6.05M | 6.42%-5.88M | -11.62%-30.09M | -3.51%-7.75M | 22.24%-6.23M | -47.33%-9.83M | -31.24%-6.28M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 15.25%-25.5M | 18.15%-6.35M | -16.07%-7.23M | 38.46%-6.05M | 6.42%-5.88M | -11.62%-30.09M | -3.51%-7.75M | 22.24%-6.23M | -47.33%-9.83M | -31.24%-6.28M |
| Basic earnings per share | 16.67%-0.2 | 16.67%-0.05 | -20.00%-0.06 | 37.50%-0.05 | 0.00%-0.05 | -14.29%-0.24 | 0.00%-0.06 | 16.67%-0.05 | -60.00%-0.08 | -25.00%-0.05 |
| Diluted earnings per share | 16.67%-0.2 | 16.67%-0.05 | -20.00%-0.06 | 37.50%-0.05 | 0.00%-0.05 | -14.29%-0.24 | 0.00%-0.06 | 16.67%-0.05 | -51.83%-0.08 | -25.00%-0.05 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call